Brief: Oncozenge Resolves On Directed Share Issue To Strategic Investor
05/06/2026 14:13
BRIEF-Oncozenge Resolves On Directed Share Issue To Strategic Investor June 5 (Reuters) - Oncozenge AB ONCOZ.ST:
ONCOZENGE RESOLVES ON A DIRECTED SHARE ISSUE TO SICHUAN YANGTIAN BIO-PHARMACEUTICAL PURSUANT TO EXISTING INVESTMENT AGREEMENT
SUBSCRIPTION PRICE OF SEK 6.47 PER SHARE
TO RECEIVE ABOUT SEK 15.1 MILLION FROM DIRECTED SHARE ISSUE
DIRECTED SHARE ISSUE COMPLETES SEK 30.2 MILLION INVESTMENT AGREEMENT
Source text: ID:nMFN2HDdvG
Further company coverage: ONCOZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))